Endothelin: a potential modulator of cerebral vasospasm

Area of Science:

• Pharmacology
• Cardiovascular Research
• Neuroscience

Background:

• Endothelin is a potent vasoactive peptide derived from endothelium.
• Endothelin induces significant vasospasm, particularly in cerebral arteries.
• Vasospasm can lead to severe neurological complications.

Purpose of the Study:

• To investigate the efficacy of 1-(5-Isoquinolinesulfonyl)-homopiperazine (HA1077) as an antagonist to endothelin-induced vasospasm.
• To evaluate HA1077's effects on canine basilar arteries both in vitro and in vivo.

Main Methods:

• In vivo studies involved inducing vasospasm with intracisternal endothelin injections in dogs.
• In vitro studies assessed the contractile activity of canine basilar arterial strips.
• HA1077's vasodilatory effects were measured using angiography and direct arterial strip analysis.

Main Results:

• Endothelin injection caused significant vasospasm in canine basilar arteries.
• HA1077 infusion resulted in significant dilatation of endothelin-induced spastic arteries.
• HA1077 effectively antagonized endothelin-induced contractions in isolated arterial strips, irrespective of calcium presence.

Conclusions:

• HA1077 demonstrates potent anti-vasospastic properties against endothelin.
• The compound acts as an effective endothelin antagonist both in vitro and in vivo.
• HA1077 shows potential therapeutic value in managing conditions associated with endothelin-mediated vasospasm.